tetramethylpyrazine has been researched along with Glomerulonephritis, IGA in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, Y; Gong, X; Hei, TK; Ye, Z; Zheng, J | 1 |
| Tang, X | 1 |
1 trial(s) available for tetramethylpyrazine and Glomerulonephritis, IGA
| Article | Year |
|---|---|
[Effect of ligustrazine on proliferative glomerulonephritis].
Topics: Adolescent; Adult; Creatinine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Losartan; Male; Middle Aged; Prednisone; Pyrazines; Serum Albumin | 2003 |
1 other study(ies) available for tetramethylpyrazine and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Tetramethylpyrazine Prevents Contrast-Induced Nephropathy via Modulating Tubular Cell Mitophagy and Suppressing Mitochondrial Fragmentation, CCL2/CCR2-Mediated Inflammation, and Intestinal Injury.
Topics: Animals; Glomerulonephritis, IGA; Inflammation Mediators; Intestines; Male; Mitochondria; Mitophagy; Pyrazines; Rats; Rats, Sprague-Dawley | 2019 |